This topic contains a solution. Click here to go to the answer

Author Question: In a goodness-of-fit test about a population distribution, if one or more parameters are left ... (Read 36 times)

geoffrey

  • Hero Member
  • *****
  • Posts: 880
In a goodness-of-fit test about a population distribution, if one or more parameters are left unspecified in H0, they must be estimated from the sample data. This will reduce the degrees of freedom by ________ for each estimated parameter.
 
  A) 1
  B) 2
  C) 3
  D) None of the above

Question 2

If the Durbin-Watson test leads you to reject the null hypothesis, then you are concluding that the forecast errors are positively autocorrelated.
 
  Indicate whether the statement is true or false



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

emsimon14

  • Sr. Member
  • ****
  • Posts: 344
Answer to Question 1

A

Answer to Question 2

TRUE





 

Did you know?

According to the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of food allergy. Food allergies affect between 4 and 6% of children, and 4% of adults, according to the CDC. The most common food allergies include shellfish, peanuts, walnuts, fish, eggs, milk, and soy.

Did you know?

Liver spots have nothing whatsoever to do with the liver. They are a type of freckles commonly seen in older adults who have been out in the sun without sufficient sunscreen.

Did you know?

Many of the drugs used by neuroscientists are derived from toxic plants and venomous animals (such as snakes, spiders, snails, and puffer fish).

Did you know?

Cutaneous mucormycosis is a rare fungal infection that has been fatal in at least 29% of cases, and in as many as 83% of cases, depending on the patient's health prior to infection. It has occurred often after natural disasters such as tornados, and early treatment is essential.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library